In brief
- A German team reviewed 44 traffic cases involving suspected nitrous oxide use and confirmed the presence of the gas in the blood of 34 individuals.
- Concentrations ranged from 0.10 to approximately 13 milliliters of gas per liter of blood—a massive range.
- Thirteen people had been involved in an accident; the others exhibited lane drifting, running red lights, or signs of confusion.
Nitrous oxide, the “laughing gas” used by dentists, is also used recreationally at parties and festivals. There is very little measured data on how it affects driving, but a study published at the end of September provides a series of real-world cases with blood analysis.
What was done
The authors, from forensic toxicology laboratories in Munich and legal medicine in Hamburg-Eppendorf, started with 44 blood samples from drivers suspected by police of being under the influence of the gas. They measured the nitrous oxide using headspace gas chromatography coupled with mass spectrometry, a technique suitable for a substance that escapes from a sample easily. They also performed standard screening for alcohol and other drugs and reviewed the police and medical reports for each case.
The gas appeared in 34 of the 44 samples. Concentrations ranged from 0.10 to about 13 milliliters per liter of whole blood. This dispersion is one of the most striking findings: there is no single value that describes a “typical driver” after inhalation, and with a substance that is eliminated in minutes, the exact timing of the blood draw is a significant factor.
What was observed on the road
The novelty compared to previous work is that they cross-referenced the analytical results with the observations noted during each police intervention. Thirteen people were involved in an accident. The others were described as performing erratic maneuvers, such as weaving between lanes or running red lights. During the police stop or blood draw, reports noted drowsiness, confusion, disorientation, slow response times, lack of concentration, slurred speech, and balance issues.
This aligns with what is known about the pharmacology of the gas. Nitrous oxide acts on NMDA receptors—the same ones blocked by ketamine and other dissociatives—and produces effects ranging from euphoria and laughter to disconnection and dizziness, depending on the quantity and frequency of inhalations. The effects are short-lived, but while they last, attention and coordination are impaired.
Study limitations
This is a case series, not an experiment. These are individuals who had already been stopped by police due to suspicion, so the group is biased toward episodes that drew attention; we do not know how many people may have driven without incident. There is no comparison group, and it is unknown how much gas each person had inhaled or how much time passed before the blood draw. The authors do not propose a “safe driving” threshold but argue that blood analysis should serve as objective evidence of recent exposure when suspicion arises.
Implications
For those who use nitrous oxide, the practical message is one of harm reduction rather than moralizing: the effect is brief, but driving requires reflexes and attention that the gas impairs while active, and the subjective feeling of being “fine again” is not a reliable metric. Waiting a significant amount of time, letting someone else drive, or planning your return trip before you start are decisions of informed autonomy, similar to those already made with other substances. On a forensic level, the study points out that there is a method to detect the gas that is almost never requested, and that its routine use would change how these cases are recorded. To understand the true extent of the impairment, research with controlled doses in a simulator will be necessary, which this series cannot offer.
If you want to broaden the framework, the harm reduction and responsible use guide contains general criteria regarding planning, intervals, and company.
Source
- Musshoff F, Müller A, Skopp GA, Herzog J. Driving under influence of nitrous oxide – a case series. Traffic Injury Prevention, September 30, 2026 (DOI 10.1080/15389588.2026.2720540).
Educational content written from a harm reduction perspective and with respect for individual freedom. It is not a substitute for advice from a healthcare professional and is not intended to encourage or condemn any drug use.
